Furthermore, this work has identified HNSCC EV protein candidates for continued evaluation, specifically tenascin-C, HLA-A, E-cadherin, EGFR, EPHA2, and cytokeratin 19. This evidence concerns the gene EPHA2 and head and neck squamous cell carcinoma.